Literature DB >> 1321494

Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript.

W A Bickmore1, K Oghene, M H Little, A Seawright, V van Heyningen, N D Hastie.   

Abstract

The technique of whole-genome polymerase chain reaction was used to study the DNA binding properties of the product of the wt1 gene. The zinc finger region of this gene is alternatively spliced such that the major transcript encodes a protein with three extra amino acids between the third and fourth fingers. The minor form of the protein binds specifically to DNA. It is now shown that the major form of wt1 messenger RNA encodes a protein that binds to DNA with a specificity that differs from that of the minor form. Therefore, alternative splicing within the DNA binding domain of a transcription factor can generate proteins with distinct DNA binding specificities and probably different physiological targets.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321494     DOI: 10.1126/science.1321494

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  50 in total

1.  Molecular basis for modulation of biological function by alternate splicing of the Wilms' tumor suppressor protein.

Authors:  J H Laity; H J Dyson; P E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

Review 2.  The possible role and application of WT1 in human leukemia.

Authors:  Z Chen
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

3.  An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1.

Authors:  Marianne K-H Kim; Thomas J McGarry; Pilib O Broin; Jared M Flatow; Aaron A-J Golden; Jonathan D Licht
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-22       Impact factor: 11.205

Review 4.  Perspectives on zinc finger protein function and evolution--an update.

Authors:  T Pieler; E Bellefroid
Journal:  Mol Biol Rep       Date:  1994-07       Impact factor: 2.316

5.  WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes.

Authors:  R C Davies; C Calvio; E Bratt; S H Larsson; A I Lamond; N D Hastie
Journal:  Genes Dev       Date:  1998-10-15       Impact factor: 11.361

6.  Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptional activity and cellular translocation.

Authors:  Y Ye; B Raychaudhuri; A Gurney; C E Campbell; B R Williams
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

7.  The Wilms tumor protein is persistently associated with the nuclear matrix throughout the cell cycle.

Authors:  Y Dobashi; T Kudoh; T Ishidate; M Shoji; K Toyoshima; T Akiyama
Journal:  Mol Cell Biochem       Date:  1997-06       Impact factor: 3.396

8.  Molecular weight abnormalities of the CTCF transcription factor: CTCF migrates aberrantly in SDS-PAGE and the size of the expressed protein is affected by the UTRs and sequences within the coding region of the CTCF gene.

Authors:  E M Klenova; R H Nicolas; S U; A F Carne; R E Lee; V V Lobanenkov; G H Goodwin
Journal:  Nucleic Acids Res       Date:  1997-02-01       Impact factor: 16.971

9.  RNA Binding by the KTS Splice Variants of Wilms' Tumor Suppressor Protein WT1.

Authors:  Tadateru Nishikawa; Jonathan M Wojciak; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2020-09-29       Impact factor: 3.162

10.  Analysis of the murine All-1 gene reveals conserved domains with human ALL-1 and identifies a motif shared with DNA methyltransferases.

Authors:  Q Ma; H Alder; K K Nelson; D Chatterjee; Y Gu; T Nakamura; E Canaani; C M Croce; L D Siracusa; A M Buchberg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.